Applied BioMath applies biosimulation, including quantitative systems pharmacology, PKPD, bioinformatics, machine learning, clinical pharmacology, and software solutions to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk therapeutic research and development. Their approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through all phases of clinical trials.
MilliporeSigma is the leading Life Science company, providing solutions as a strategic partner to help advance the promise of life saving therapies. We have the largest offering of products for formulations, actives and biotechnology processes. Our joint ADC offering includes a full range of integrated contract manufacturing services for drug development and manufacturing that spans conjugation, mAbs, linkers and payloads. To fit your ADC manufacturing needs, we offer a comprehensive processing portfolio from cell culture media to buffers, salts and stabilizers and from chromatography to TFF equipment, including single-use templates.
Shenzhen Enduring Biotech
Shenzhen Enduring Biotech is an innovative company that committed to develop more effective and safer therapeutics to meet unmet clinical needs. Based on the unique next generation conjugation technology, Enduring has built two drug development technology platforms: PEG based T-cell engager Bispecific Antibody (P-T-BsAb) technology platform and PEGylated Bispecific ADC (P-BsADC) technology platform. The advantages of dual heterobifunctional linker technology have been fully demonstrated with our lead compounds as showed in our preclinical studies.
We are Abzena. More than a CDMO, we are a responsible and dedicated Partner Research Organization (PRO) that takes care of your products from concept to patient. With extensive experience in developing biologics and bioconjugates, we offer a seamless service delivered by fully integrated teams, from early discovery to commercial manufacturing. Forward-thinking and committed, we find the best solution and use the right technologies to design, develop and manufacture your products to ensure we get vital medicines to patients quickly and safely. We are dedicated to quality excellence. We are driven to get better treatments to market, efficiently and responsibly by reducing timelines and delivering the highest quality products and services.
BSP Pharmaceuticals is a Contract Development and Manufacturing Organization fully dedicated to antineoplastic drugs, designed to handle the complexity of biopharmaceutical products and offering customized services to support its client from development to commercial manufacturing of injectables and oral formulations. BSP Pharmaceuticals is focused on innovative therapies such as Proteosome Inhibitors, Antibody Drug Conjugates (ADCs) , Liposomal formulations, handling the major platforms of ADC compounds currently in clinical and commercial phase.
Singzyme’s ligase-based conjugation technology enables the site-specific attachment of a wide variety of payloads to proteins including antibodies and nanobodies. Singzyme’s one-step precision technology allows rapid bioconjugation, including for dual payloads, with controllable Drug-to-Antibody Ratio and low impact on antibody activity / tumour penetration. Singzyme’s technology therefore significantly shortens the ADC development time and helps bring more homogeneous drugs faster to clinics for the benefit of cancer patients.
Scilligence’s informatics solutions enhance knowledge sharing and productivity of researchers in the discovery and development of small molecule and biologics therapeutics, including conjugates. Our knowledge mining tools enable chemical structure search across various data sources and file types, allowing our customers access to information previously bound by technology silos. Our project/workflow management and inventory systems improve productivity and safety compliance. Scilligence’s applications are designed to minimize IT footprints and require no client-side installation.
SpectronRx teams are proven experts in monoclonal antibody labeling, with a variety of isotopes. We are a logistics champion of import/export, and a top-tier expert in world procurement of isotopes. We are your experienced early-stage to commercialization contract developer with a global and domestic respected outreach in radiotherapy. The varied and experienced SpectronRx team bring you the excellence needed for rapid advancement towards key milestones and increased demand for early phase therapeutic and diagnostic development services. SpectronRx can be your END-to-END solution for ALL critical phases of drug development, now or scalable to your budget and timeline
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We perform ADC sample preparation, small scale development services, customized facility design, and superior scale up of early stage processes for late stage and commercial supply. Backed by a strong reputation for industry leading analytical capabilities and quality control, Lonza can also aide in driving quick development and improving marketability of the industry’s high potential future therapies Contact email@example.com or visit
Goodwin Biotechnology’s mission is to eliminate the manufacturing risk for companies developing complex biologic therapeutics by being the pre-eminent provider of high-quality, cost-effective, flexible and timely cGMP compliant manufacturing solutions, from pre-clinical development through commercial product supply. By integrating our services in one location, Goodwin provides a Single Source Solution™ to anticipate and overcome the challenges you face with your biopharmaceutical candidate, whether it be complex proteins such as monoclonal antibodies or a sophisticated Antibody Drug Conjugate (ADC).
NJ Bio, Inc.
NJ Bio, Inc. is a US-based CRO that provides high-quality integrated chemistry and biology services for bioconjugations and ADCs to biotech and pharmaceutical companies – from start-up to big pharma. Main service areas include linker-payload synthesis for ADCs, bioconjugations and antibody-drug conjugates as well as bioassay and bioanalytical services. With our expertise and experience in the ADC field, we strive to create value for our clients by advancing their programs. Please contact firstname.lastname@example.org or visit our website.
Formed in 2015, PROVEO is now a Division of Cerbios- Pharma SA focused on complete supply chain solution for Antibody Drug Conjugates (ADCs).
Thanks to the partnership with AGC Biologics and Oncotec, PROVEO offer best-in-class solutions for the integrated development and cGMP manufacturing of recombinant proteins (incl mAbs), cytotoxic drug-linker payload, conjugation, aseptic fill and lyophilization. Strengths of the three PROVEO partners secure a seamless and low risk ADC supply chain for clinical and commercial projects.
JOINN Biologics, a premier NorCal based CRDMO, provides research, accelerated drug development and manufacturing services for protein-based biologics. We offer a comprehensive range of services across all the phases of protein and protein-based drug life cycle, including CLD, MCB manufacturing, protein conjugation, process and analytical development, formulation development, drug substance manufacturing, and IND enabling PKPD/Tox assessment. Our one-stop service will cover all your protein production and conjugation needs. We strive to ensure quality, efficiency and consistency in all that we do to better support our client’s needs and timelines.
Minakem (160 m€ sales) is developing and manufacturing small molecules (including highly potent APIs) and Payload-Linkers for CMC activities and at commercial scale. Minakem is also a well-known custom manufacturer of complex, advanced intermediates, including purification by HPLC, under strict cGMP (EMEA, USFDA) conditions for the pharmaceutical industry. All development activities are conducted by highly skilled R&D technical teams supported by strong and state-of-the-art analytical services including solid form and QbD laboratories.
Created from the merger of Novasep, Farmabios and PharmaZell, Axplora is a leading CDMO and API partner to pharmaceutical and biotech companies, supporting them throughout the entire drug lifecycle.
Leveraging our combined expertise and manufacturing capabilities across nine industrial sites, Axplora offers CDMO services and specialized technologies to innovators as well as API products.
The group provides unique services for the development, clinical and commercial cGMP manufacture of ADCs including the payload-linker and the bioconjugation.